Clinical trial
Intravenous Immunoglobulin Therapy in Optic Neuritis
NCT00000117 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00000117 |
|---|---|
| Title | Intravenous Immunoglobulin Therapy in Optic Neuritis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Optic Neuritis |
| Intervention type | Drug |
| Interventions | Immunoglobulin |
| Start date | Aug 1, 1995 |
| Completion | Dec 1, 1997 |
| First posted | Sep 24, 1999 |
| Last update posted | Sep 17, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: